Status:
COMPLETED
Effectiveness of CDT for the Treatment of Lymphedema in Breast Cancer Patients Who Received LVA Surgery
Lead Sponsor:
Fundacion Universitaria Maria Cano
Conditions:
Breast Cancer Lymphedema
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Breast cancer is the most common type of cancer in women worldwide. Advances in treatment have increased survival rates, so patients must live with the complications resulting from the cancer and its ...
Detailed Description
Breast cancer is the most common type of cancer among women, with an estimated 2.3 million new cases diagnosed worldwide in 2020, with especially high incidence in developed countries. The five-year s...
Eligibility Criteria
Inclusion
- Patients with lymphedema due to cancer.
- Patients who have undergone lymphovenous anastomosis surgery in the past 12 months
Exclusion
- Decompensated heart failure
- Decompensated renal failure
- Open wounds
- Decompensated arterial insufficiencies
Key Trial Info
Start Date :
February 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06569719
Start Date
February 1 2024
End Date
December 30 2024
Last Update
January 17 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Fundación Universitaria María Cano
Medellín, Antioquia, Colombia, 0000
2
Fundación Universitaria María cano
Medellín, Antioquia, Colombia, 05000